Inventor · disambiguated record
Gerhard Dickneite
Also filed as: DICKNEITE GERHARD · DICKNEITE GERHARD DR
28 granted patents·8 pending applications·483 citations·filing 1984–2016
97Inventor score
Top patents by PatentIndex Score
36 records- 0194US5284856AOncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivativesHOECHST AG·Filed 1992·Granted Feb 8, 1994·87 cites·3 claims
- 0290US5561119AGlycosylated prodrugs, their method of preparation and their usesHOECHST LAB·Filed 1992·Granted Oct 1, 1996·107 cites·36 claims
- 0387US6248365B1Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpuraAVENTIS BEHRING GMBH·Filed 1993·Granted Jun 19, 2001·64 cites·6 claims
- 0486US4578399AUse of the diterpene derivative forskolin for immunostimulationHOECHST AG·Filed 1984·Granted Mar 25, 1986·26 cites·4 claims
- 0583US5079263AManumycin derivatives and the use thereofBEHRINGWERKE AG·Filed 1988·Granted Jan 7, 1992·38 cites·5 claims
- 0682US9987328B2Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfacesCSL BEHRING GMBH·Filed 2016·Granted Jun 5, 2018·4 cites·20 claims
- 0780US8394768B2Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentratesDICKNEITE GERHARD·Filed 2007·Granted Mar 12, 2013·4 cites·5 claims
- 0876US7276235B2Tissue glue with improved antiadhesive propertiesZLB BEHRING GMBH·Filed 2002·Granted Oct 2, 2007·33 cites·30 claims
- 0975US8603979B2von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytesDICKNEITE GERHARD·Filed 2009·Granted Dec 10, 2013·4 cites·24 claims
- 1074US9352016B2Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfacesZEITLER STEFAN·Filed 2012·Granted May 31, 2016·5 cites·17 claims
- 1172US9624307B2Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organsNAHRENDORF MATTHIAS·Filed 2012·Granted Apr 18, 2017·5 cites·13 claims
- 1271US4762848A1,3-thiazoles and their use as immunomodulatorsHOECHST AG·Filed 1986·Granted Aug 9, 1988·10 cites·18 claims
- 1369US8580737B2Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentratesDICKNEITE GERHARD·Filed 2012·Granted Nov 12, 2013·1 cites·20 claims
- 1469US4699912AUse of Lycorine as an immunosuppressorBEHRINGWERKE AG·Filed 1985·Granted Oct 13, 1987·14 cites·3 claims
- 1568US5457114AAmidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulantsBEHRINGWERKE AG·Filed 1994·Granted Oct 10, 1995·21 cites·14 claims
- 1667US4603137AImmunosuppressive chromone alkaloidHOECHST AG·Filed 1984·Granted Jul 29, 1986·11 cites·2 claims
- 1766US6399572B1Pharmaceutical preparation for the treatment of inflammatory processesAVENTIS BEHRING GMBH·Filed 2000·Granted Jun 4, 2002·4 cites·6 claims
- 1865US9452203B2Use of C1-inhibitor for the treatment of secondary edema of the central nervous systemCSL BEHRING GMBH·Filed 2012·Granted Sep 27, 2016·1 cites·30 claims
- 1965US9095564B2von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytesCSL BEHRING GMBH·Filed 2013·Granted Aug 4, 2015·1 cites·20 claims
- 2062US2010143973A1Interleukin-11 Fusion ProteinsKROEZ MONIKA·Filed 2009·Application pending·0 cites
- 2158US5627283AAmidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulantsBEHRINGWERKE AG·Filed 1995·Granted May 6, 1997·15 cites·1 claims
- 2257US2008292581A1Interleukin-11 Fusion ProteinsDELTA BIOTECHNOLOGY LTD·Filed 2004·Application pending·0 cites
- 2355US5571784AUse of VWF-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapyBEHRINGWERKE AG·Filed 1995·Granted Nov 5, 1996·13 cites·2 claims
- 2454US5006515APharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained thereinHOECHST AG·Filed 1988·Granted Apr 9, 1991·7 cites·11 claims
- 2549US2012258072A1Interleukin-11 Fusion ProteinsKROEZ MONIKA·Filed 2011·Application pending·0 cites
- 2647US6790832B2Pharmaceutical preparation for the treatment of inflammatory processesAVENTIS BEHRING GMBH·Filed 2002·Granted Sep 14, 2004·0 cites·6 claims
- 2744US4847299AUse of 15-deoxyspergualine as a pharmaceuticalBEHRINGWERKE AG·Filed 1987·Granted Jul 11, 1989·3 cites·8 claims
- 2840US2002001584A1Tissue glue with improved antiadhesive propertiesAVENTIS BEHRING GMBH·Filed 2001·Application pending·0 cites
- 2940US2007167361A1Use of factor XIII for stimulating the perfusion of ischemic tissueINBAL AIDA·Filed 2005·Application pending·0 cites
- 3038US4701452AUse of cephem compounds as immunomodulatorsHOECHST AG·Filed 1985·Granted Oct 20, 1987·2 cites·2 claims
- 3137US11155601B2Modified von Willebrand factor having improved half-lifeCSL Behring Lengnau AG·Filed 2016·Granted Oct 26, 2021·0 cites·13 claims
- 3236US5849799AUse of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseasesBEHRINGWERKE AG·Filed 1995·Granted Dec 15, 1998·2 cites·10 claims
- 3336US2018043012A1Compounds for improving the half-life of von willebrand factorCSL BEHRING RECOMBINANT FACILITY AG·Filed 2016·Application pending·0 cites
- 3433US2013177547A1Ancestral serine protease coagulation cascade exerts a novel function in early immune defenseHERWALD HEIKO·Filed 2011·Application pending·0 cites
- 3530US2004214756A1Pharmaceuticals for treating sepsis and septic shockAVENTIS BEHRING GMBH·Filed 1997·Application pending·0 cites
- 3629US6207877B1Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleedingAVENTIS BEHRING GMBH·Filed 1999·Granted Mar 27, 2001·1 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Gerhard Dickneite files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →